<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33898792</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-6502</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>eNeurologicalSci</Title><ISOAbbreviation>eNeurologicalSci</ISOAbbreviation></Journal><ArticleTitle>Post-COVID seizure: A new feature of "long-COVID".</ArticleTitle><Pagination><StartPage>100340</StartPage><MedlinePgn>100340</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100340</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ensci.2021.100340</ELocationID><Abstract><AbstractText>Novel coronavirus SARS-CoV-2 has created unprecedented healthcare challenges. Neurologic deficits are often an important presenting symptom. To date, the only reported post-infectious COVID-19 manifestations of neurologic disease include cognitive deficits and dysfunction of the peripheral nervous system. Here we report that seizure can also be a post-COVID-19 or "long-COVID" complication. We present a 71-year-old man with hypertension, diabetes mellitus, and COVID-19 diagnosed by RT-PCR who initially presented with posterior circulation stroke-like symptoms, which completely resolved after emergent thrombolysis. Six days later, the patient returned with seizure activity, supported by radiographic and electroencephalographic studies. Notably, he was negative for SARS-CoV-2, and no other provoking factor was uncovered after a comprehensive work-up. To our knowledge, this is the first report of post-infectious seizures after a case of COVID-19, highlighting the potential importance of monitoring for neurologic symptoms in COVID-19 patients, even after convalescence.</AbstractText><CopyrightInformation>&#xa9; 2021 Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kincaid</LastName><ForeName>Keith J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kung</LastName><ForeName>Justin C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senetar</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendoza</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonnin</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purtlebaugh</LastName><ForeName>Windy L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabatbat</LastName><ForeName>Rainier M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Medstar Washington Hospital Center, Comprehensive Stroke Center, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickens</LastName><ForeName>Rondalyn</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Echevarria</LastName><ForeName>Franklin D</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kariyawasam</LastName><ForeName>Vidhu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruzzone</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpkins</LastName><ForeName>Alexis N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>University of Florida, Department of Neurology, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>eNeurologicalSci</MedlineTA><NlmUniqueID>101667077</NlmUniqueID><ISSNLinking>2405-6502</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Post-infectious seizure</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Seizure</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33898792</ArticleId><ArticleId IdType="pmc">PMC8053221</ArticleId><ArticleId IdType="doi">10.1016/j.ensci.2021.100340</ArticleId><ArticleId IdType="pii">S2405-6502(21)00032-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nouh A., Remke J., Ruland S. Ischemic posterior circulation stroke: a review of anatomy, clinical presentations, diagnosis, and current management. Front. Neurol. 2014;5:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3985033</ArticleId><ArticleId IdType="pubmed">24778625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli S.G., Dogan L., Sarikaya Z.T. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020;297(1):E232&#x2013;E235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507997</ArticleId><ArticleId IdType="pubmed">32384020</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. Apr 1 2020;11(7):995&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman C., Mayer K., Sarwal A. Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology. 2020;95(2):77&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">32345728</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal S., Mansur M. COVID-19 presenting with seizures. IDCases. 2020;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194035</ArticleId><ArticleId IdType="pubmed">32363146</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyrouti R., Adams M.E., Benjamin L. Characteristics of ischaemic stroke associated with COVID-19. J. Neurol. Neurosurg. Psychiatry. 2020;91(8):889&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7231545</ArticleId><ArticleId IdType="pubmed">32354768</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkler A.E., Parikh N.S., Mir S. Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza. JAMA Neurol. Jul 2020;77(11):1366&#x2013;1372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333175</ArticleId><ArticleId IdType="pubmed">32614385</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephson S.A., Kamel H. Neurology and COVID-19. JAMA. 2020;324(12):1139&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pubmed">32960246</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry R.J., Smith C.J., Roffe C. Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study. J. Neurol. Neurosurg. Psychiatry. Nov 2020;92(3):242&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">33154179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez Amezcua J.M., Jain R., Kleinman G. COVID-19-induced neurovascular injury: a case series with emphasis on pathophysiological mechanisms. SN Compr. Clin. Med. 2020;2(11):2109&#x2013;2125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577845</ArticleId><ArticleId IdType="pubmed">33106782</ArticleId></ArticleIdList></Reference><Reference><Citation>Leira E.C., Russman A.N., Biller J. Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions. Neurology. Jul 21 2020;95(3):124&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455350</ArticleId><ArticleId IdType="pubmed">32385186</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgamasy S., Kamel M.G., Ghozy S., Khalil A., Morra M.E., Islam S.M.S. First case of focal epilepsy associated with SARS-coronavirus-2. J. Med. Virol. 2020;92(10):2238&#x2013;2242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300744</ArticleId><ArticleId IdType="pubmed">32484990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan R.E., Grinspan Z., Axeen E., Marquis B., Day B.K. COVID-19 in patients with seizures and epilepsy: interpretation of relevant knowledge of presenting signs and symptoms. Epilepsy Curr. Sep 2020;20(5):312&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445677</ArticleId><ArticleId IdType="pubmed">32833573</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquisiras-Burgos I., Peralta-Arrieta I., Alonso-Palomares L.A., Zacapala-G&#xf3;mez A.E., Salmer&#xf3;n-B&#xe1;rcenas E.G., Aguilera P. Neurological complications associated with the blood-brain barrier damage induced by the inflammatory response during SARS-CoV-2 infection. Mol. Neurobiol. Feb 2021;58(2):520&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518400</ArticleId><ArticleId IdType="pubmed">32978729</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P., Rothan H.A., Natekar J.P. Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. Viruses. 2021;13(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Nair G. Microvascular injury in the brains of patients with covid-19. N. Engl. J. Med. Dec 2020;384:481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Somani S., Pati S., Gaston T., Chitlangia A., Agnihotri S. De novo status epilepticus in patients with COVID-19. Ann. Clin. Transl. Neurol. Jul 2020;7(7):1240&#x2013;1244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273010</ArticleId><ArticleId IdType="pubmed">32407609</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikbakht F., Mohammadkhanizadeh A., Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Mult. Scler. Relat. Disord. Nov 2020;46:102535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521932</ArticleId><ArticleId IdType="pubmed">33010584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M., Ruan X., Li Y. Clinical characteristics of 30 COVID-19 patients with epilepsy: a retrospective study in Wuhan. Int. J. Infect. Dis. 2021;103:647&#x2013;653. doi: 10.1016/j.ijid.2020.09.1475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.1475</ArticleId><ArticleId IdType="pmc">PMC7531277</ArticleId><ArticleId IdType="pubmed">33017697</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabezudo-Garc&#xed;a P., Ciano-Petersen N.L., Mena-V&#xe1;zquez N., Pons-Pons G., Castro-S&#xe1;nchez M.V., Serrano-Castro P.J. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology. 2020;95(10):e1417&#x2013;e1425.</Citation><ArticleIdList><ArticleId IdType="pubmed">32554773</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. Dec 2020;21:100276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Golenbock D., Latz E., Morgan D., Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res. Ther. 2020;12(1):69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T., Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J. Neurol. Sci. 2020;419:117179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550857</ArticleId><ArticleId IdType="pubmed">33070003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndwandwe D., Mathebula L., Kamadjeu R., Wiysonge C.S. Cochrane corner: rapid point-of-care antigen and molecular-based tests for the diagnosis of COVID-19 infection. Pan Afr. Med. J. 2020;37(Suppl. 1):10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704347</ArticleId><ArticleId IdType="pubmed">33294111</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: timing is critical for antibody tests, finds Cochrane review. BMJ. Jun 25 2020;369:m2584.</Citation><ArticleIdList><ArticleId IdType="pubmed">32586794</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>